Switch to:

Navidea Biopharmaceuticals Inc (NAVB) Ownership Data

Short Interest History (%)

This is the historical short interest of Navidea Biopharmaceuticals Inc, as measured by the Short Percentage Of Float.

Date Short Interest
June 15, 201519.59
May 29, 201519.17
May 15, 201519.11
April 30, 201519.27
April 15, 201519.57
March 31, 201519.76
March 13, 201519.74
February 27, 201519.42
February 13, 201520.4
January 30, 201520.58
January 15, 201520.53
December 31, 201420.94
December 15, 201421.41
November 28, 201419.85
November 14, 201417.14
October 31, 201417.02
October 15, 201416.82
September 30, 201416.91
September 15, 201416.51
August 29, 201416.3
August 15, 201416.3
July 31, 201416.24
July 15, 201416.48
June 30, 201415.68
June 13, 201414.92
May 30, 201414.33
May 15, 201413.82
April 30, 201413.53
April 15, 201413.45
March 31, 201412.78
March 14, 201412.1
February 28, 201412.47
February 14, 201415.81
January 31, 201415.52
January 15, 201415.48
December 31, 201315.81
December 13, 201316.07
November 29, 201315.84
November 15, 201315.9
October 31, 201316.4
October 15, 201315.85
September 30, 201316.75
September 13, 201316.81
August 30, 201317.02
August 15, 201317.81
July 31, 201318.26
July 15, 201319.27
June 28, 201320.04
June 14, 201320.63
May 31, 201320.79
May 15, 201321
April 30, 201321.59
April 15, 201321.43
March 28, 201320.84
March 15, 201317.77
February 28, 201321.47
February 15, 201320.35
January 31, 201319.16
January 15, 201317.93
December 31, 201217.5
December 14, 201218.44
November 30, 201218
November 15, 201217.57
October 31, 201217.05
October 15, 201216.57
September 28, 201216.51
September 14, 201217.17
August 31, 201216.61
August 15, 201214.67
July 31, 201217.74
July 13, 201217.23
June 29, 201216.08
June 15, 201215.55
May 31, 201214.62
May 15, 201213.9
April 30, 201213.28
April 13, 201213.11
March 30, 201212.34
March 15, 201212.29
February 29, 201211.95
February 15, 201212.69
January 31, 201212.15
January 13, 201212.44
December 15, 201112.55
November 30, 201112.71
November 15, 201112.59
October 31, 201112.57
October 14, 201112.67
September 30, 201113.05
September 15, 201113.42
August 31, 201113.87
August 15, 201113.28
July 29, 201112.49
July 15, 201112.86
June 30, 201114.27
June 15, 201110.23
May 31, 20119.14
May 13, 20117.13
April 29, 20116.48
April 15, 20116.26
March 31, 20116.44
March 15, 20115.64
February 28, 20118.62
February 15, 20118.57

Institutional Ownership History (%)

This the Institutional Ownership History of Navidea Biopharmaceuticals IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
June 30, 201534
March 31, 201534
December 31, 201432
September 30, 201436
June 30, 201436
March 31, 201436
December 31, 201337
September 30, 201324
June 30, 201326
March 31, 201329
December 31, 201224
September 30, 201225
June 30, 201229
March 31, 201218
December 31, 201118
September 30, 201119
June 30, 201121
March 31, 20115
December 31, 20108
December 31, 200736
December 31, 20052
September 30, 20052
June 30, 20052
December 31, 20041
September 30, 20042
June 30, 20042
March 31, 20043
December 31, 20031
September 30, 20033
June 30, 20032
March 31, 20039
December 31, 20025
September 30, 20023
June 30, 20024
March 31, 20024
December 31, 20014
September 30, 200110
June 30, 200110
March 31, 200110
December 31, 20003
September 30, 20003
June 30, 20003
March 31, 20003

Insider ownership (%)

This is the historical insider ownership of Navidea Biopharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
April 30, 20154
March 31, 20154
February 28, 20153
January 31, 20153
December 31, 20143
November 30, 20143
October 31, 20143
September 30, 20143
August 31, 20143
March 31, 20124
February 29, 20124
January 31, 20124
December 31, 20114
November 30, 20114
October 31, 20114
September 30, 20114
August 31, 20114
July 31, 20114
June 30, 20114
May 31, 20114
April 30, 20113
March 31, 20112
February 28, 20112
January 31, 20112
December 31, 20102
November 30, 20102
October 31, 20102
September 30, 20102
August 31, 20102
July 31, 20102
June 30, 20102
May 31, 20102
April 30, 20102
March 31, 20102
February 28, 20102
January 31, 20102
December 31, 20092
November 30, 20092
October 31, 20092
September 30, 20092
August 31, 20092
July 31, 20092
June 30, 20092
May 31, 20092
April 30, 20092
March 31, 20092
February 28, 20092
January 31, 20092
December 31, 20082
November 30, 20082
October 31, 20082
September 30, 20082
August 31, 20082
July 31, 20082
June 30, 20082
May 31, 20082
April 30, 20083
March 31, 20083
February 29, 20083
January 31, 20082
December 31, 20072
November 30, 20072
October 31, 20072
September 30, 20072
August 31, 20072
July 31, 20072
June 30, 20072
May 31, 20072
April 30, 20072
March 31, 20072
February 28, 20072
January 31, 20072
December 31, 20062
November 30, 20062
October 31, 20062
September 30, 20062
June 30, 20062
May 31, 20062
April 30, 20066
March 31, 20066
February 28, 20066
January 31, 20066
December 31, 20056
November 30, 20056
October 31, 20056
September 30, 20056
August 31, 20056
July 31, 20056
June 30, 20056
May 31, 20056
April 30, 20056
March 31, 20051
February 28, 20051
January 31, 20051
December 31, 20041
November 30, 20041
October 31, 20041
September 30, 20041
August 31, 20041
July 31, 20041
June 30, 20041
May 31, 20041
April 30, 20041
March 31, 20041

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Michael M. Goldberg,M.D.Director318,3250.21%2015-03-26
Dr. Mark J. Pykett,PhD,V.M.D.CEO312,6740.21%2014-06-01
Brent L. LarsonEVP, CFO, Treas and Sec'y284,7370.19%2015-07-01
Brendan A. FordDirector230,6330.15%2015-05-21
Gordon A. TroupDirector211,7550.14%2015-03-26
Dr. Eric K. Rowinsky,M.D.Director185,7200.12%2015-03-26
Rodger A. BrownVice President123,027less than 0.1%2013-03-13
Dr. Peter F. Drake,PhDDirector99,839less than 0.1%2015-03-26
Dr. Frederick O. Cope,PhDSVP75,814less than 0.1%2014-03-10
Dr. Thomas H. TulipEVP & Chief Business officer70,773less than 0.1%2015-03-26

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Platinum Management (ny) Llc   Premium Plus11,454,8312015-03-317.6162.7418,213,000
Commerzbank AG   Premium Plus6,702,0022015-03-314.450.0610,656,000
Susquehanna Financial Group, LLLP   Premium Plus6,084,0762015-03-314.040.009,674,000
Vanguard Group, Inc.   Premium Plus4,514,7182015-03-313.000.007,178,000
BlackRock Fund Advisors   Premium Plus4,206,9222015-03-312.790.006,689,000
Goldman, Sachs & Co.   Premium Plus3,216,7792015-03-312.140.005,115,000
Platinum Liquid Opportunity Management (NY) LLC2,486,3972015-02-201.660.004,003,099
iShares Russell 2000 (AU)2,373,2522015-07-021.640.013,987,063
Vanguard Total Stock Mkt Idx2,347,4702015-05-311.560.002,934,338
State Street Corp   Premium Plus2,047,9892015-03-311.360.003,256,000

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK